Patents by Inventor Robert Khan

Robert Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240134811
    Abstract: The following description is directed to a configurable logic platform. In one example, a configurable logic platform includes host logic and a reconfigurable logic region. The reconfigurable logic region can include logic blocks that are configurable to implement application logic. The host logic can be used for encapsulating the reconfigurable logic region. The host logic can include a host interface for communicating with a processor. The host logic can include a management function accessible via the host interface. The management function can be adapted to cause the reconfigurable logic region to be configured with the application logic in response to an authorized request from the host interface. The host logic can include a data path function accessible via the host interface. The data path function can include a layer for formatting data transfers between the host interface and the application logic.
    Type: Application
    Filed: October 24, 2023
    Publication date: April 25, 2024
    Inventors: Islam Atta, Christopher Joseph Pettey, Asif Khan, Robert Michael Johnson, Mark Bradley Davis, Erez Izenberg, Nafea Bshara, Kypros Constantinides
  • Publication number: 20240122555
    Abstract: A framework for troubleshooting medical imaging equipment. Log event data and state data of one or more components of the medical imaging equipment are received. One or more calculations are performed based on the log event data and state data to generate processed data. One or more representations of the one or more components of the medical imaging equipment may then be generated based on the processed data, the log event data, the state data, or a combination thereof.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 18, 2024
    Inventors: John Pawlak, Antje Spade, Daniel Dobrescu, Bernardo Hermont, Kausar Khan, Robert Peter Hurley, III, Micah Sovereign
  • Publication number: 20240116896
    Abstract: The present disclosure provides N,N-dimethyltryptamine (N,N-DMT) derivatives of the present disclosure provides compounds of formula (I), (I-A), (I-B), (I-C), (II), (II-A), (III), and (IV), or pharmaceutically acceptable salts or deuterated forms thereof. Also provided herein are methods of using the N,N-DMT derivatives, e.g., in the treatment of mental health diseases and/or disorders.
    Type: Application
    Filed: September 6, 2023
    Publication date: April 11, 2024
    Inventors: Tanweer A. KHAN, Alan C. GIBBS, Glenn SHORT, Robert B. PERNI
  • Patent number: 11948365
    Abstract: An identity of a customer within an establishment is authenticated using a variety of captured biometric features obtained from sensors and/or video. Video capturing movements/interactions of the customer is analyzed in real time to identify the customer's behavior and actions. Any staff of the establishment who interact with the customer are identified from the video. Transaction data and other data retained for the customer by the establishment are aggregated and linked with the video and the customer identity. The linked data is analyzed in combination with the customer behavior and actions to determine responses within the establishment to customer-initiated transactions. In an embodiment, the customer is authorized to perform at least one transaction within the establishment based on the authenticated identity and linked data without a presentation by the customer of an identification card, a Personal Identification Number (PIN), a password and/or verification by a staff member.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: April 2, 2024
    Assignee: NCR Voyix Corporation
    Inventors: Sudip Rahman Khan, Matthew Robert Burris, Christopher John Costello, Gregory Joseph Hartl
  • Patent number: 11926574
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, e.g., in the treatment of a mental health disease or disorder.
    Type: Grant
    Filed: June 8, 2022
    Date of Patent: March 12, 2024
    Assignee: Atai Therapeutics Inc.
    Inventors: Glenn Short, Robert B. Perni, Benjamin Robert Difrancesco, Tanweer A. Khan
  • Patent number: 11912680
    Abstract: Provided herein are compounds of Formula (I), Formula (II), and Formula (III) or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7 and A are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), Formula (II), or Formula (III) and methods of using a compound of Formula (I), Formula (II), or Formula (III), e.g., in the treatment of a mental health disease or disorder.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: February 27, 2024
    Assignee: EmpathBio, Inc.
    Inventors: Robert B. Perni, Glenn Short, Tanweer A. Khan
  • Patent number: D900088
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: October 27, 2020
    Assignee: Everi Payments Inc.
    Inventors: Michael Aughney, Jessica Barreto, Francisco Perez, Robert Khan, Thomas Quick
  • Patent number: D925519
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: July 20, 2021
    Assignee: Everi Payments Inc.
    Inventors: Michael Aughney, Jessica Barreto, Francisco Perez, Robert Khan, Thomas Quick
  • Patent number: D956036
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: June 28, 2022
    Assignee: Everi Payments Inc.
    Inventors: Michael Aughney, Jessica Barreto, Francisco Perez, Robert Khan, Thomas Quick